143 related articles for article (PubMed ID: 19430118)
1. Construction of an infectious cDNA clone of foot-and-mouth disease virus type O 1 BFS 1860 and its use in the preparation of candidate vaccine.
Hema M; Chandran D; Nagendrakumar SB; Madhanmohan M; Srinivasan VA
J Biosci; 2009 Mar; 34(1):45-58. PubMed ID: 19430118
[TBL] [Abstract][Full Text] [Related]
2. Rescue of infective virus from a genome-length cDNA clone of the FMDV serotype O (IND-R2/75) vaccine strain and its characterization.
Rajasekhar R; Hosamani M; Basagoudanavar SH; Sreenivasa BP; Tamil Selvan RP; Saravanan P; Venkataramanan R
Res Vet Sci; 2013 Aug; 95(1):291-7. PubMed ID: 23465777
[TBL] [Abstract][Full Text] [Related]
3. Construction and characterization of a full-length infectious cDNA clone of foot-and-mouth disease virus strain O/JPN/2010 isolated in Japan in 2010.
Nishi T; Onozato H; Ohashi S; Fukai K; Yamada M; Morioka K; Kanno T
Res Vet Sci; 2016 Jun; 106():165-9. PubMed ID: 27234555
[TBL] [Abstract][Full Text] [Related]
4. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.
Blignaut B; Visser N; Theron J; Rieder E; Maree FF
J Gen Virol; 2011 Apr; 92(Pt 4):849-59. PubMed ID: 21177923
[TBL] [Abstract][Full Text] [Related]
5. Study of a chimeric foot-and-mouth disease virus DNA vaccine containing structural genes of serotype O in a genome backbone of serotype Asia 1 in guinea pigs.
Chockalingam AK; Thiyagarajan S; Govindasamy N; Patnaikuni R; Garlapati S; Golla RR; Joyappa DH; Krishnamshetty P; Veluvarti VV
Acta Virol; 2010; 54(3):189-95. PubMed ID: 20822311
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics.
Li P; Bai X; Sun P; Li D; Lu Z; Cao Y; Fu Y; Bao H; Chen Y; Xie B; Liu Z
BMC Vet Res; 2012 May; 8():57. PubMed ID: 22591597
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and protective efficacy of 3A truncated negative marker foot-and-mouth disease virus serotype A vaccine.
Dhanesh VV; Hosamani M; Basagoudanavar SH; Saravanan P; Biswal JK; Tamil Selvan RP; Madhavan A; Sehrish K; Sanyal A; Sreenivasa BP
Appl Microbiol Biotechnol; 2020 Mar; 104(6):2589-2602. PubMed ID: 32002597
[TBL] [Abstract][Full Text] [Related]
8. [Rescue of bovine Asia 1 serotype foot-and-mouth disease virus from a full-length cDNA clone].
Li S; Zhang R; Song G; Gao M; Liu X; Wang J
Sheng Wu Gong Cheng Xue Bao; 2009 Nov; 25(11):1621-6. PubMed ID: 20222458
[TBL] [Abstract][Full Text] [Related]
9. Intra-serotype SAT2 chimeric foot-and-mouth disease vaccine protects cattle against FMDV challenge.
Maree FF; Nsamba P; Mutowembwa P; Rotherham LS; Esterhuysen J; Scott K
Vaccine; 2015 Jun; 33(25):2909-16. PubMed ID: 25930116
[TBL] [Abstract][Full Text] [Related]
10. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of T7 bacteriophage nanoparticles displaying G-H loop of foot-and-mouth disease virus (FMDV).
Xu H; Bao X; Lu Y; Liu Y; Deng B; Wang Y; Xu Y; Hou J
Vet Microbiol; 2017 Jun; 205():46-52. PubMed ID: 28622860
[TBL] [Abstract][Full Text] [Related]
12. Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.
Barrera J; Schutta C; Pisano M; Grubman MJ; Brake DA; Miller T; Kamicker BJ; Olutunmbi F; Ettyreddy D; Brough DE; Butman BT; Neilan JG
Vaccine; 2018 Feb; 36(8):1078-1084. PubMed ID: 29358056
[TBL] [Abstract][Full Text] [Related]
13. The rescue and selection of thermally stable type O vaccine candidate strains of foot-and-mouth disease virus.
Gao Y; Li P; Ma X; Bai X; Sun P; Du P; Yuan H; Cao Y; Li K; Fu Y; Zhang J; Bao H; Chen Y; Li Z; Lu Z; Liu Z; Li D
Arch Virol; 2021 Aug; 166(8):2131-2140. PubMed ID: 34003358
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.
Singanallur NB; Pacheco JM; Arzt J; Stenfeldt C; Fosgate GT; Rodriguez L; Vosloo W
Antiviral Res; 2017 Sep; 145():114-122. PubMed ID: 28780422
[TBL] [Abstract][Full Text] [Related]
15. Development of foot-and-mouth disease virus (FMDV) serotype O virus-like-particles (VLPs) vaccine and evaluation of its potency.
Mohana Subramanian B; Madhanmohan M; Sriraman R; Chandrasekhar Reddy RV; Yuvaraj S; Manikumar K; Rajalakshmi S; Nagendrakumar SB; Rana SK; Srinivasan VA
Antiviral Res; 2012 Dec; 96(3):288-95. PubMed ID: 23043941
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant effect of saponin in an oil-based monovalent (serotype O) foot-and-mouth disease virus vaccine on the antibody response in guinea pigs and cattle.
Bazid AI; El-Alfy HA; El-Didamony G; Elfeil WK; El-Sayed MM; Fawzy M
Arch Virol; 2021 Jul; 166(7):1977-1984. PubMed ID: 33871696
[TBL] [Abstract][Full Text] [Related]
17. The effect of bovine IFN-alpha on the immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus.
Guo HC; Liu ZX; Sun SQ; Leng QW; Li D; Liu XT; Xie QG
Acta Biochim Biophys Sin (Shanghai); 2004 Oct; 36(10):701-6. PubMed ID: 15483751
[TBL] [Abstract][Full Text] [Related]
18. Comparison of immune responses to different foot-and-mouth disease genetically engineered vaccines in guinea pigs.
Yao Q; Qian P; Huang Q; Cao Y; Chen H
J Virol Methods; 2008 Jan; 147(1):143-50. PubMed ID: 17963851
[TBL] [Abstract][Full Text] [Related]
19. Novel chimeric foot-and-mouth disease virus-like particles harboring serotype O VP1 protect guinea pigs against challenge.
Li H; Li Z; Xie Y; Qin X; Qi X; Sun P; Bai X; Ma Y; Zhang Z
Vet Microbiol; 2016 Feb; 183():92-6. PubMed ID: 26790940
[TBL] [Abstract][Full Text] [Related]
20. Generation of an infectious cDNA clone of an FMDV strain isolated from swine.
Liu G; Liu Z; Xie Q; Chen Y; Bao H; Chang H; Liu X
Virus Res; 2004 Sep; 104(2):157-64. PubMed ID: 15246653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
